Clinical Trial Update: Collection of Efficacy and Safety Data of Chinese Patients Who Have Received Faslodex 250mg Treatment

View source ↗

Summary

A terminated AstraZeneca-sponsored clinical trial is collecting efficacy and safety data from Chinese breast cancer patients treated with Faslodex (fulvestrant)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: TERMINATED